Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | +3.90% | -7.94% | -21.20% |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
05-08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.20% | 162M | |
-23.07% | 8.1B | |
+67.36% | 4.26B | |
+1.88% | 2.57B | |
-8.06% | 2.49B | |
-41.95% | 2.39B | |
-11.87% | 1.77B | |
-21.29% | 1.53B | |
+17.44% | 1.2B | |
-43.89% | 1.18B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcript : Biodesix, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 09